Social relations and the metabolic syndrome in middle-aged Swedish women

European Journal of Preventive Cardiology

Volumn 6, Issue 6, 1999, Pages 391-397

  Horsten, Myriam ^a   Mittleman, Murray A ^b   Wamala, Sarah P ^a   Schenck Gustafsson, Karin ^c   Orth Gomér, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cardiovascular disease; metabolic syndrome; social isolation; women's health

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL ISOLATION; SWEDEN; SYNDROME X;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIFE STYLE; LIPIDS; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SOCIAL ISOLATION; SOCIAL SUPPORT; SWEDEN; SYNDROME; VON WILLEBRAND FACTOR;

EID: 84992904119     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748739900600606     Document Type: Article

References (59)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
2. Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Fujimoto WY, et al Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 1998; 147: 441–447.
3. Meigs JB, D'Agostino RB, Wilson PWF, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 1997; 46: 1594–1600.
4. Kaplan NM. The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989; 149: 1514–1520.
5. Zimmet PZ. Challenges in diabetes epidemiology: from West to the rest. Diabetes Care 1992; 15: 232–252.
6. Alberti KGMM, Zimmet PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus [provisional report of a WHO consultation]. Diabetic Med 1998; 15: 539–553.
7. Berkman LF, Syme SL. Social networks, host resistance and mortality: a nine year follow-up study of Alameda County residents. Am J Epidemiol 1979; 109: 186–204.
8. Orth-Gomér K, Johnson J. Social network interaction and mortality: a six year follow-up of a random sample of the Swedish population. J Chron Dis 1987; 40: 949–957.
9. Orth-Gomér K, Rosengren A, Wilhelmsen L. Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med 1993; 55: 37–43.
10. Berkman LF, Leo-Summers L, Horwittz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 1992; 117: 1003–1009.
11. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988; 241: 540–545.
12. Cohen S. Psychosocial models of the role of social support in the etiology of physical disease. Healthy Psychol 1988; 7: 269–297.
13. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 1996; 119: 488–531.
14. Kirschbaum C, Klauer T, Filipp S-H, Hellhammer DH. Sex-specific effects of social support on Cortisol and subjective responses to acute psychological stress. Psychosom Med 1995; 57: 23–31.
15. Levine S. The influence of social factors on the response to stress. Psychother Psychosom 1993; 60: 33–38.
16. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb 1991; 11: 1250–1257.
17. Ravaja N, Keltikangas-Jarvinen L, Viikari J. Perceived social support and abdominal fat distribution in adolescents and young adults: a structural equation analysis of prospective data. Appetite 1998; 31: 21–35.
18. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132–1143.
19. Fukunishi I, Akimoto M, Horikawa N, Shirasaka K, Yamazaki T. Stress coping and social support in glucose tolerance abnormality. J Psychosom Res 1998; 45: 361–369.
20. Romeisjö A, Hasin D, Hilton M, Boström G, Diderichsen F, Haglund B, et al The relationship between stressful working conditions and high alcohol consumption and severe alcohol problems in an urban general population. Br J Addict 1992; 87: 1173–1183.
21. Cohen S, Mermelstein R, Kamarek T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR (editors): Social support: theory research and applications. Dordrecht: Martinus Nijholt; 1985. pp. 73–94.
22. Willet WC, Sampson L, Stampfer J, Rosner B, Bain C, Witschi J, et al Reproducibility and validity of semi quantitative food frequency questionnaire. Am J Epidemiol 1995; 122: 51–65.
23. Myrhed M. Alcohol consumption in relation to factors associated with ischemic heart disease: a cotwin control study. Acta Med Scand Suppl 1974; 567: 1–93.
24. Colditz GA, Willett WC, Stampfer MJ, Sampson L, Rosner B, Hennekens CH, et al The influence of age, relative weight, smoking and alcohol intake on the reproducibility of a dietary questionnaire. Int J Epidemol 1987; 16: 392–398.
25. Horsten M, Wamala SP, Vingerhoets A, Orth-Gomér K. Depressive symptoms, social support and lipid-profile in healthy middle-aged women. Psychosom Med 1997; 59: 521–528.
26. Vermylen C, De Vreker RA, Verstraete M. A rapid enzymatic method for assay fibrinogen: fibrin polymerization time (FPT test). Clin Chim Acta 1963; 8: 418–424.
27. Amiral J, Adalbert B, Adam M. Application of enzyme immuno assay to coagulation testing. Clin Chem 1984; 30: 1512–1516.
28. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992; 80: 25–28.
29. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantification of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734–744.
30. Silveira A, Green F, Karper F, Blombäck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994; 72: 734–739.
31. Wiman B, Chmielewska J, Ranby M. Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. J Biol Chem 1984; 259: 3644–3657.
32. Wamala SP, Mittleman AM, Horsten M, Eriksson M, Hamsten A, Silveira A etal: Socioeconomic status and determinants of hemostatic function in healthy women. Arteriosci Thromb Vasc Biol 1999; 19: 485–492.
33. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24–27.
34. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of Apolipoprotein A-1 and B in serum. Scand J Clin Lab Invest 1987; 7: 739–744.
35. JMP statistics for the Apple Macintosh version 3.1. SAS Institute Inc.; 1994.
36. Stata Corporation. Stata reference manual. Release 3.1. Sixth edition. College Station, TX; 1993.
37. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123: 174–184.
38. Eriksson M, Egberg N, Wamala S, Orth-Gomér K, Mittleman MA, Schenck-Gustafsson K. Relationship between plasma fibrinogen and coronary heart disease in women. Arterioscl Thromb Vasc Biol 1999: 19: 67–72.
39. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, et al Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044–1048.
40. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, et al Associations of factor VII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380–385.
41. Eliasson M, Asplund K, Evrin P-E, Lindahl B, Lundblad D. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the northern Sweden MONICA study. Metabolism 1994; 43: 1579–1586.
42. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998; 21: 649–654.
43. Wielgosz AT. Impact of the social environment on blood pressure in women. Can J Cardiol 1996; 12: 13D–15D.
44. Rosengren A, Orth-Gomér K, Wedel H, Wilhelmsen L. Low serum cholesterol, social support, and predictors of mortality in middle-aged men: a study of men born in 1933. Cardiovasc Risk Factors 1996; 6: 345–353.
45. Treiber FA, Batanowski T, Braden DS, Strong WB, Levy M, Knox W. Social support for exercise: relationship to physical activity in young adults. Prevent Med 1991; 20: 737–750.
46. Oka RK, King AC, Young D. Rohm Sources of social support as predictors of exercise adherence in women and men ages 50 to 65 years. Women's Health 1995; 1: 161–175.
47. Julius S. Sympathetic hyperactivity and coronary risk in hypertension [Corcoran lecture]. Hypertension 1993; 21: 886–893.
48. Schneiderman N, Skyler JS. Insulin metabolism, sympathetic nervous system regulation, and coronary heart disease prevention. In: Orth-Gomér K, Schneiderman N (editors): Behavioral medicine approaches to cardiovascular disease prevention. New Jersey: Lawrence Erlbaum Associates Inc.; 1996. pp. 105–133.
49. Horsten M, Ericson M, Perski A, Wamala S, Schenck-Gustafsson K, Orth-Gomér K. Psychosocial factors and heart rate variability in healthy women. Psychosom Wed 1999; 61: 49–57.
50. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 91: 1936–1943.
51. Hayano J, Skakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, et al Accuracy of assessment of cardiac vagal tone by HRV in normal subjects. Am J Cardiol 1991; 67: 199–204.
52. Undén A-L, Orth-Gomér K, Elofsson S. Cardiovascular effects of social support in the work place: twenty-four-hour ECG monitoring of men and women. Psychosom Med 1991; 53: 50–60.
53. Andersson L. Intervention against loneliness in a group of elderly women: an impact evaluation. Soc Sci Med 1985; 20: 355–364.
54. Björntorp P. Behavior and metabolic disease. Int J Behav Med 1996; 3: 285–302.
55. Björntorp P. Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J Intern Med 1991; 230: 195–201.
56. Rosmond R, Björntorp P. Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 1998; 6: 338–345.
57. Rosmond R, Lapidus L, Marin P, Björntorp P. Mental distress, obesity and body fat distribution in middle-aged men. Obes Res 1996; 4: 245–252.
58. Zlotnick C, Shea MT, Pilkonis PA, Elkin I, Ryan C. Gender, type of treatment, dysfunctional attitudes, social support, life events, and depressive symptoms over naturalistic follow-up. Am J Psychiatr 1996; 153: 1021–1027.
59. Oxman TE, Berkman LF, Kasl S, Freeman DH, Barrett J. Social support and depressive symptoms in the elderly. Am J Epidemiol 1992; 135: 356–368.